Education
About Us
Working with TipRanks
Follow Us
Eric Easom Insider Profile
11 Followers
Eric Easom, CEO, Director at AN2 Therapeutics, Inc., holds 1.63M shares in AN2 Therapeutics, Inc. (Ticker: ANTX).
Eric Easom AN2 Therapeutics, Inc. (ANTX)CEO, Director
AN2 Therapeutics, Inc. (ANTX)
CEO, Director
Ranked #10,916 out of 106,487 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+100.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Eric Easom holds in companies
Most Profitable Insider Trade
The most profitable trade made by Eric Easom
Eric Easom's Trading History
List of latest transactions for each holding click on a transaction to see Eric Easom's performance on stock
You May Also Like
Eric Easom insider profile FAQ
What is the percentage of profitable transactions made by Eric Easom?
The percentage of profitable transactions made by Eric Easom is 67%.
What is the average return per transaction made by Eric Easom?
The average return per transaction made by Eric Easom is 100.90%.
What stocks does Eric Easom hold?
Eric Easom holds: ANTX stocks.
What was Eric Easom’s latest transaction?
Eric Easom latest transaction was an Uninformative Buy of ―.
What was Eric Easom's most profitable transaction?
Eric Easom’s most profitable transaction was an Informative Buy of ANTX stock on June 3, 2025. The return on the trade was 349.00%.
What is Eric Easom's role in AN2 Therapeutics, Inc.?
Eric Easom's role in AN2 Therapeutics, Inc. is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.